EU Novel Food Authorization: Regulation (EU) 2015/2283 Explained

Getting an EU novel food authorization under Regulation (EU) 2015/2283 means proving to European authorities that a food not eaten to a significant degree in the EU before May 15, 1997, is safe to sell. Two routes exist: a full application that runs through the European Commission, the European Food Safety Authority (EFSA), and a committee of member state representatives, and a lighter notification procedure for foods with a documented 25-year history of safe use outside the EU. On paper the full process takes about 18 months. In practice, most authorizations run two and a half years or longer.¹

When You Actually Need an Authorization

The trigger is simple. If a food was not consumed to a significant degree by people in the EU before May 15, 1997, it counts as novel. That cutoff is fixed, regardless of when a particular country joined the EU.²

The food also has to fall within one of the ten categories in Article 3(2). Those categories reach broadly: new molecular structures; foods from microorganisms, fungi, algae, or minerals; plants and animals produced by methods not traditional in the EU before 1997; cell and tissue cultures; foods made by new production processes that significantly change composition or nutrition; engineered nanomaterials with dimensions of 100 nanometers or less; vitamins and minerals made by novel processes; and ingredients previously used only in food supplements that a business now wants to put in other foods.²

That last category traps businesses regularly. An ingredient with decades of legitimate use in EU food supplements still needs a fresh authorization the moment someone wants to put it in a cereal, a beverage, or a snack bar.

Confirming Novel Status Before You Spend Money

The first step is not filing an application. It’s finding out whether you need one.

The European Commission maintains a Novel Food Catalogue, a searchable database of plant and animal products, algal and fungal species, and other substances with indications of their novel food status.³ The catalogue is non-binding and non-exhaustive, so it points you in a direction but does not settle close cases.

When the catalogue doesn’t resolve the question, Article 4 requires the business to consult the authorities of the member state where it first intends to sell the food. The business has to build the evidence itself. Sales receipts, import records, and official documentation of consumption before 1997 carry weight; anecdote generally does not.² The outcome is shared with the Commission and other member states and published, so it builds precedent for later applicants.

Skipping this step is expensive. Businesses that assume their product is not novel and start selling face enforcement action, recalls, and the cost of filing an application retroactively while their revenue is frozen.

The Full Authorization Pathway

Once a product is confirmed novel, Article 10 sets out the standard route. Three institutions handle three stages.

Submission and Validity Check

The applicant uploads a completed dossier through the Commission’s electronic submission platform.⁴ The Commission then has 30 working days to check that the application meets administrative requirements. If something is missing, the clock resets on resubmission. Once valid, the application goes to EFSA and a summary is made public.⁵

EFSA Risk Assessment

EFSA has nine months from receiving a valid application to adopt a scientific opinion on whether the food is safe under the proposed conditions of use. The nine-month clock stops whenever EFSA asks the applicant for more information, and it does not restart until the applicant responds.⁵ Almost all serious delays come from here. A dossier that leaves obvious gaps invites round after round of questions.

Commission Decision and Union List Entry

After EFSA delivers its opinion, the Commission has seven months to draft an implementing act. The draft goes to the Standing Committee on Plants, Animals, Food and Feed, where every member state votes.⁵ A favorable vote adds the food to the Union List, which sets out its authorized conditions of use, labeling, and specifications. Authorizations are generic: any business can sell an authorized novel food under those conditions, unless the original applicant secured data protection.⁶

The Traditional-Food Shortcut

Not every novel food needs the full pathway. Under Article 14, foods from countries outside the EU that have been part of the customary diet somewhere for at least 25 continuous years can use a lighter notification procedure.⁷ The reasoning: decades of widespread real-world consumption is itself a form of safety evidence.

The notification has to include the food’s identity, detailed composition, country of origin, and documented evidence of safe use in at least one non-EU country. Compositional data and the consumption record do most of the work; toxicological testing is not the focus. All supporting documents must be in English, according to EFSA’s traditional-food guidance.⁸

Once the Commission validates the notification, it forwards the file to all member states and EFSA within one month. A four-month objection window opens. Any member state or EFSA can raise safety objections, but the objections have to rest on scientific evidence.⁷ No objections means authorization and Union List entry. Objections shut the notification pathway, but the applicant can convert to a full authorization application to address the concerns raised.

What the Dossier Has to Contain

The dossier is where applications are won or lost. EFSA’s guidance sets the required content, and it covers several areas.

Identity and Production

The food must be identified precisely. For biological sources, that means taxonomic classification; for purified chemicals, Chemical Abstracts Service registry numbers. The production description has to give a reviewer enough to understand every stage, including temperatures, pressures, solvents, and sterilization methods, so EFSA can judge whether the process introduces contaminants or unintended byproducts.

Composition and Stability

Analytical data has to show what the food contains, including nutrients and any contaminants of concern such as heavy metals. Batch-to-batch analyses demonstrate consistent manufacturing. Stability data covers how composition changes across shelf life.

Proposed Uses and Intake

The dossier must state exactly how the food will be used: which food categories, maximum concentrations, and the intended consumer population. EFSA uses this to model dietary exposure across age groups and eating patterns and to check that even heavy consumers stay within safe limits.⁹

Toxicology and Nutrition

Safety testing is tiered. Baseline requirements include genotoxicity testing, starting with a bacterial reverse mutation assay and an in vitro micronucleus assay, with follow-up in vivo studies if the initial results raise concerns. A 90-day oral toxicity study in rodents is often needed when compositional analysis cannot rule out safety concerns.¹⁰ All toxicological studies must follow Good Laboratory Practice principles. Nutritional data is also required, to confirm the food doesn’t displace more nutritious alternatives from the diet.

Engineered nanomaterials carry an extra requirement: applicants must explain why their chosen testing methods are scientifically appropriate at the nanoscale and describe any adaptations made to standard protocols.²

Pre-Submission Study Notification

Since the Transparency Regulation (Regulation (EU) 2019/1381), applicants have to notify EFSA of studies commissioned to support a future application at the time those studies are commissioned. The point is to keep companies from burying unfavorable results.¹¹ EFSA publishes practical arrangements on how to submit these notifications.¹² Missing the notification window doesn’t automatically invalidate a study, but it invites scrutiny and damages credibility with reviewers.

What It Costs and How Long It Really Takes

Neither the Commission nor EFSA charges a fee for processing novel food applications. The costs sit entirely on the applicant: commissioning toxicological studies, preparing the dossier, and paying regulatory consultants. A 90-day feeding study in rodents alone can run into six figures, and a full dossier for a genuinely novel substance typically needs several studies. Businesses coming in with regulatory experience from other jurisdictions often underestimate the bill, because no other major food safety system asks for exactly the same package of data.

The statutory clocks add up to roughly 18 months if nothing goes wrong: one month for validity check, nine months for EFSA, seven months for the Commission’s implementing act. In reality, EFSA clock-stops and committee scheduling push most cases past two and a half years. Plan for two to three years at minimum, longer for products that raise new safety questions such as cell-cultured foods or engineered nanomaterials. Cell-cultured food is explicitly covered by the sixth Article 3(2) category, and as of early 2026 five cell culture-derived foods have been authorized in the EU, all from plant cells; EFSA received its first application for a cell culture-derived food of animal origin in September 2024.¹³

EFSA runs a dedicated support desk for small and medium enterprises preparing novel food applications, offering fast-tracked advice, help with submission tools, and teleconferences. General pre-submission advice is open to any applicant.⁹ Using these services early is one of the few reliable ways to head off the dossier gaps that trigger clock-stops.

Protecting Your Data After Authorization

Authorizations are generic, so a competitor can sell the same food under the Union List conditions without doing any of the safety research. Article 26 gives the original applicant a partial remedy: five years of data protection, measured from the date of authorization. During that window, newly developed scientific evidence or data submitted with the application cannot be used to support a competitor’s application without the original applicant’s consent.²

To qualify, three conditions have to be met. The data must be flagged as proprietary at the time of the original application. The applicant must have held exclusive rights to reference the data when the application was filed. And EFSA must not have been able to assess and authorize the food without that specific data.

Data protection is not available for traditional food notifications, and it does not stop a competitor from generating its own independent safety data and filing separately. It only prevents free-riding on your proprietary research.²

What Can Stay Confidential

Article 23 allows applicants to request confidential treatment for information that could harm their competitive position if disclosed, with a verifiable justification. The regulation draws a hard line around what can never be kept confidential: the applicant’s name and address, the name and description of the food, a summary of the studies submitted, the results of safety studies, the proposed conditions of use, and any restriction or prohibition imposed on the same food by a non-EU country.

If the Commission rejects a confidentiality request, the applicant has three weeks to withdraw the entire application, and confidentiality is preserved during that window. After three weeks, the Commission’s position takes effect.² In practice, manufacturing process details and proprietary analytical methods are the elements most commonly granted confidential treatment; the safety data itself stays public.

Labeling and Ongoing Duties

Authorization is not the finish line. Each Union List entry sets the labeling conditions for that food, and those conditions are legally binding. Where nutritional profile or composition differs materially from a conventional counterpart, the label must say so. Foods that could trigger allergic reactions or that are unsuitable for particular groups such as young children or pregnant women carry additional disclosures.

Under Article 24, the Commission can impose post-market monitoring case by case when the safety assessment leaves uncertainties that only real-world consumption data can resolve.⁷ Article 25 places a continuing duty on any business selling an authorized novel food: if new scientific information emerges that could affect the safety evaluation, or if a non-EU country restricts or bans the food, the business must notify the Commission immediately.² The Commission then passes the information to all member states.

Penalties for Selling Without Authorization

The regulation does not set EU-wide penalty amounts. Article 29 requires each member state to establish its own penalties, subject to one constraint: they must be effective, proportionate, and dissuasive.² The financial consequences of selling an unauthorized novel food therefore vary substantially across the EU. Some member states impose fixed fines; others use graded systems tied to company size or the severity of the infringement. National authorities can also order recalls, seize inventory, and issue public warnings that often do more commercial damage than any fine.

1
European Commission. Novel Food
2
EUR-Lex. Regulation (EU) 2015/2283 of the European Parliament and of the Council
3
European Commission. Novel Food Status Catalogue
4
European Commission. E-Submission in Accordance With the New Novel Foods Regulation
5
European Commission. E-Submission System for Novel Foods User Guide
6
European Commission. Union List of Novel Foods
7
EUR-Lex. Regulation (EU) 2015/2283 of the European Parliament and of the Council (Consolidated)
8
European Food Safety Authority. Revision of the Guidance on Traditional Foods – Outcome of the Public Consultation
9
European Food Safety Authority. Novel Food Application Procedure
10
European Food Safety Authority. Guidance on the Scientific Requirements for an Application for Authorisation of a Novel Food
11
European Commission. Transparency and Sustainability of the EU Risk Assessment in the Food Chain
12
European Food Safety Authority. Transparency Regulation and Stakeholder Engagement
13
European Food Safety Authority. Novel Food